Inclusion Body Myositis Clinical Trials

40 clinical trials for Inclusion Body Myositis across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Adult and Juvenile Myositis — RECRUITING
• Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease — RECRUITING · NA
• MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS) — RECRUITING
• Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders — RECRUITING
• The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period. — RECRUITING · NA
• A PHASE II/III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO DETERMINE THE EFFICACY AND SAFETY OF ABC008 IN THE TREATMENT OF SUBJECTS WITH INCLUSION BODY MYOSITIS — RECRUITING · PHASE2
• Simvastatin treatment in inclusion body myositis (IBM) — COMPLETED · PHASE3
• Environmental Risk Factors for Myositis in Military Personnel — COMPLETED
• Emerging Indications for Hyperbaric Oxygen Treatment — NOT_YET_RECRUITING · PHASE4
• Monitoring Biomarker for Detecting Change in Physical Activity and Limb Function in Inclusion Body Myositis Over Time — ACTIVE_NOT_RECRUITING
• BIGTIM: Blocking Interferon-γ by ruxolitinib for Treating Inclusion body Myositis: a phase IIb trial. — TERMINATED · PHASE2
• Sporadic Inclusion Body Myositis Natural History Study — ACTIVE_NOT_RECRUITING
• IBM Dietary Surveillance Study — NOT_YET_RECRUITING
• A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Efficacy and Safety of ABC008 in the Treatment of Subjects with Inclusion Body Myositis — OTHER · PHASE3
• An Open-label, Multicenter Study to Evaluate the Long-term Safety and Efficacy of Ulviprubart (ABC008) in Subjects Who Have Completed a Trial of Ulviprubart for the Treatment of Inclusion Body Myositis — OTHER · PHASE3
• A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis — COMPLETED · PHASE2
• Phase III Trial of Sirolimus in IBM — ACTIVE_NOT_RECRUITING · PHASE3
• Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells — COMPLETED · NA
• Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis — COMPLETED · PHASE2
• Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis — ACTIVE_NOT_RECRUITING · PHASE2
• Exercise as Treatment for Patients With Inclusion Body Myositis — COMPLETED · NA
• AN OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF ULVIPRUBART (ABC008) IN SUBJECTS WHO HAVE COMPLETED A TRIAL OF ULVIPRUBART FOR THE TREATMENT OF INCLUSION BODY MYOSITIS — COMPLETED
• A Phase 1 Study of ABC008 in Ascending (Single Ascending Dose/Multiple Ascending Dose) Study in Patients With (IBM) — COMPLETED · PHASE1
• Cell therapy for Inclusion Body Myositis (IBM) by muscle injection of autologous uncultured Adipose-Derived Stromal Vascular Fraction (ADSVF): a phase I trial — TERMINATED · PHASE2
• Safety and Tolerability of Phenylbutyrate in Inclusion Body Myositis — COMPLETED · PHASE1
• The Risk of Falls Index for Patients With Neuromuscular Disorders — COMPLETED
• Pompe & Pain - Study to Assess Nociceptive Pain in Adult Patients With Pompe Disease — OTHER
• Arimoclomol in Sporadic Inclusion Body Myositis - Open Label Extension Trial — TERMINATED · PHASE3
• Study of Arimoclomol in Inclusion Body Myositis (IBM) — COMPLETED · PHASE2
• Molecular Profile of the Evolution of Inclusion Body Myositis — COMPLETED · NA
• Cell Therapy for IBM by Muscle Injection of ADSVF — OTHER · PHASE1
• Study of Pioglitazone in Sporadic Inclusion Body Myositis — COMPLETED · PHASE1
• Establishing Muscle Impedance Parameters With Electrical Impedance Myography — COMPLETED
• Natalizumab in Inclusion Body Myositis (IBM) — OTHER · PHASE1
• Arimoclomol in Sporadic Inclusion Body Myositis — COMPLETED · PHASE2
• Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis — COMPLETED · PHASE1
• Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis — COMPLETED
• Anakinra in Myositis — COMPLETED · PHASE2
• Lithium in Inclusion Body Myositis (IBM) — COMPLETED
• Intravenousimmunoglobulin (IVIg) for the Treatment of Inflammatory Myopathies — COMPLETED · PHASE2

Refine this search